99 related articles for article (PubMed ID: 18172184)
1. Early thimerosal exposure and neuropsychological outcomes.
Bernard S
N Engl J Med; 2008 Jan; 358(1):93; author reply 94. PubMed ID: 18172184
[No Abstract] [Full Text] [Related]
2. Early thimerosal exposure and neuropsychological outcomes.
Rooney JP
N Engl J Med; 2008 Jan; 358(1):93-4; author reply 94. PubMed ID: 18175387
[No Abstract] [Full Text] [Related]
3. Early thimerosal exposure and neuropsychological outcomes at 7 to 10 years.
Thompson WW; Price C; Goodson B; Shay DK; Benson P; Hinrichsen VL; Lewis E; Eriksen E; Ray P; Marcy SM; Dunn J; Jackson LA; Lieu TA; Black S; Stewart G; Weintraub ES; Davis RL; DeStefano F;
N Engl J Med; 2007 Sep; 357(13):1281-92. PubMed ID: 17898097
[TBL] [Abstract][Full Text] [Related]
4. Neonatal exposure to Thimerosal from vaccines and child development in the first 3 years of life.
Mrozek-Budzyn D; Majewska R; Kieltyka A; Augustyniak M
Neurotoxicol Teratol; 2012; 34(6):592-7. PubMed ID: 23069197
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines.
Tozzi AE; Bisiacchi P; Tarantino V; De Mei B; D'Elia L; Chiarotti F; Salmaso S
Pediatrics; 2009 Feb; 123(2):475-82. PubMed ID: 19171612
[TBL] [Abstract][Full Text] [Related]
6. Thimerosal exposure in early life and neuropsychological outcomes 7-10 years later.
Barile JP; Kuperminc GP; Weintraub ES; Mink JW; Thompson WW
J Pediatr Psychol; 2012; 37(1):106-18. PubMed ID: 21785120
[TBL] [Abstract][Full Text] [Related]
7. United Nations mercury treaty jeopardizes vaccine protection of the world's most vulnerable children.
Durrheim DN; Poland GA
Vaccine; 2013 Feb; 31(10):1357-8. PubMed ID: 23414666
[No Abstract] [Full Text] [Related]
8. Early exposure to thimerosal-containing vaccines and children's cognitive development. A 9-year prospective birth cohort study in Poland.
Mrozek-Budzyn D; Majewska R; Kiełtyka A
Eur J Pediatr; 2015 Mar; 174(3):383-91. PubMed ID: 25185528
[TBL] [Abstract][Full Text] [Related]
9. Modeling neurodevelopment outcomes and ethylmercury exposure from thimerosal-containing vaccines.
Dórea JG; Marques RC
Toxicol Sci; 2008 Jun; 103(2):414-5; author reply 416. PubMed ID: 18364366
[No Abstract] [Full Text] [Related]
10. Mercury, infant neurodevelopment, and vaccination.
Pless R; Risher JF
J Pediatr; 2000 May; 136(5):571-3. PubMed ID: 10802484
[No Abstract] [Full Text] [Related]
11. Letter to the editor. The safety of thimerosal in newborn and infant vaccines.
Thompson WW; DeStefano F; Chen R
Vaccine; 2004 Dec; 23(3):281-2. PubMed ID: 15530668
[No Abstract] [Full Text] [Related]
12. Thimerosal in vaccines: a joint statement of the American Academy of Pediatrics and the Public Health Service.
Neonatal Netw; 1999 Sep; 18(6):65, 72. PubMed ID: 10690100
[No Abstract] [Full Text] [Related]
13. Safety of thimerosal-containing vaccines: a two-phased study of computerized health maintenance organization databases.
Verstraeten T; Davis RL; DeStefano F; Lieu TA; Rhodes PH; Black SB; Shinefield H; Chen RT;
Pediatrics; 2003 Nov; 112(5):1039-48. PubMed ID: 14595043
[TBL] [Abstract][Full Text] [Related]
14. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
Rooney JP
Pediatrics; 2008 Oct; 122(4):902; author reply 902-3. PubMed ID: 18829819
[No Abstract] [Full Text] [Related]
15. The antimicrobial activity of phenoxyethanol in vaccines.
Lowe I; Southern J
Lett Appl Microbiol; 1994 Feb; 18(2):115-6. PubMed ID: 7764595
[TBL] [Abstract][Full Text] [Related]
16. Mercury levels in newborns and infants after receipt of thimerosal-containing vaccines.
Pichichero ME; Gentile A; Giglio N; Umido V; Clarkson T; Cernichiari E; Zareba G; Gotelli C; Gotelli M; Yan L; Treanor J
Pediatrics; 2008 Feb; 121(2):e208-14. PubMed ID: 18245396
[TBL] [Abstract][Full Text] [Related]
17. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink.
Young HA; Geier DA; Geier MR
J Neurol Sci; 2008 Aug; 271(1-2):110-8. PubMed ID: 18482737
[TBL] [Abstract][Full Text] [Related]
18. Thimerosal disappears but autism remains.
Fombonne E
Arch Gen Psychiatry; 2008 Jan; 65(1):15-6. PubMed ID: 18180423
[No Abstract] [Full Text] [Related]
19. Neurodevelopmental disorders following thimerosal-containing childhood immunizations: a follow-up analysis.
Geier D; Geier MR
Int J Toxicol; 2004; 23(6):369-76. PubMed ID: 15764492
[TBL] [Abstract][Full Text] [Related]
20. Exposure to mercury during the first six months via human milk and vaccines: modifying risk factors.
Dórea JG
Am J Perinatol; 2007 Aug; 24(7):387-400. PubMed ID: 17564957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
